Chapter 44: Contraceptive Implants

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine placing a flexible piece of plastic, like no bigger than a matchstick, just under the skin of someone's arm.

Right.

And for the next three years, that tiny, you know, invisible sliver quietly hijacks their entire endocrine system.

It really does.

It's fascinating.

I mean, there are no daily pills to remember, no user errors to worry about, just this invisible, continuous biology ticking away in the background.

It is a completely different kind of clinical intervention.

It absolutely is.

You know, when you are suturing a wound or setting a bone, the precision is entirely visual.

It's immediate.

Right, you can see what you're doing.

Exactly.

But with long -acting reversible contraception, the physical procedure is just a tiny fraction of the work, the real heavy lifting.

The true clinical precision happens in the conversation, the physiological profiling, and the anticipatory guidance before you ever even touch an insertion tool.

Welcome to this deep dive.

If you are listening right now, you are likely a nursing or advanced practice student, or maybe you're a clinician gearing up for practice and you're staring down this massive mountain of material.

Which can be overwhelming, for sure.

So our mission today is to translate the really dense, complex clinical guidelines from Chapter 44 on contraceptive implants into a plain language, highly memorable study session.

Yeah, we're taking you through the exact clinical workflow.

Exactly.

We will start with the physical device and its pharmacology, then move into patient counseling and navigating side effects, and finish up with the exact anatomical steps for safe insertion.

And understanding the underlying logic is really the key to clinical readiness here.

When you understand the physiological why behind the implant's design, you aren't just memorizing a dry list of contraindications or side effects for a test.

Right, it actually makes sense.

Yeah, the clinical guidelines naturally make sense.

That cause and effect relationship makes the knowledge infinitely easier to recall.

Whether you are sitting for a high stakes board exam or standing in an exam room with a patient who's looking to you for answers.

Okay, let's unpack this.

Before we even think about selecting the right patient for this method, we really need to understand the hardware.

What exactly are we putting into the patient's arm and what is it made of?

Right, so we are working with the etanogestral implant, which is specifically known by the brand name Nexbalon.

Right.

Physically, it is a single rod, subdermal, progestin only implant.

It measures just four centimeters in length and about two millimeters in diameter.

So really tiny.

Very tiny.

And the core structure is made from an ethylene vinyl acetate copolymer.

Okay, that sounds like a very fancy medical grade plastic.

It essentially is.

It's a highly flexible biocompatible material,

but its most important feature is that it is porous on a microscopic level.

Oh, interesting.

Yeah, so it doesn't just hold the hormone.

It actually allows the etanogestral to slowly and continuously seep out into the surrounding tissue and bloodstream over a period of years.

And it hasn't always been the Nexbalon device we use today, right?

I mean, there was an older version called Implanon.

Why the change?

Yeah, Implanon was approved by the FDA back in 2006,

but it had a couple of really significant clinical hurdles that led to the Nexbalon upgrade in 2011.

Well, kind of hurdles.

The biggest issue was that if a clinician

accidentally inserted the Implanon rod too deeply, like, into the muscle instead of just under the skin, it could migrate.

Oh, wow.

And because the original rod was just plain plastic, it was completely invisible on an X -ray.

Finding a lost implant basically became a surgical scavenger hunt.

That sounds like an absolute nightmare.

So for the Nexbalon upgrade, they basically added barium sulfate to the plastic, so it acts like a microscopic GPS tracker, right?

Yeah, exactly.

So if the device ever gets lost or migrates, you just take a standard X -ray.

And because of the barium, it glows bright white.

It is completely radio opaque.

That radio opacity completely revolutionized the safety profile.

And to prevent that deep insertion from happening in the first place, they completely overhaul the insertion applicator.

Oh, they changed the tool itself.

Yeah, the new tool is physically designed to force the clinician to keep the needle shallow.

It goes in almost parallel to the skin, which drastically reduces the chance of an intramuscular placement.

That makes a lot of sense.

So let's talk about the medication inside it.

You mentioned the hormone slowly seeps out.

How much is actually getting into the patient's system?

The rod is loaded with 68 micrograms of eutinogestrel.

Initially, during those first few weeks, it releases a steady dose of about 60 to 70 micrograms per day.

Okay.

But that rate doesn't stay flat.

As the months go by, the release rate slowly and steadily tapers down.

By the time the patient reaches year three, the implant is only releasing about 25 to 30 micrograms per day.

Wait, if the hormone level is dropping that significantly by the third year, how is it still effective?

Because, I mean, the efficacy numbers are staggering.

They really are.

The failure rate is measured by the PERL index, which looks at how many women out of 100 would get pregnant in a year of use.

The PERL index for Nexplanon is 0 .38.

That means statistically less than half of one woman out of 100 gets pregnant.

Out of over 20 ,000 cycles studied, there were only six reported pregnancies.

And even those were likely conceptions right before insertion or right after removal.

What's fascinating here is how that steady decline in hormone release still maintains that incredibly high efficacy for a full three years.

Right, how does it do that?

It really comes down to the sheer potency of a ton of gestural and the multi -layered defense it mounts in the body.

It doesn't rely on just one single physiological change to prevent pregnancy, it relies on four.

Okay, let's break down those four mechanisms because understanding how this alters the patient's biology is crucial for everything that comes next.

Absolutely.

The primary mechanism is the inhibition of ovulation.

Okay, so stopping the egg.

Right, the steady stream of progestin travels to the brain and suppresses the release of luteinizing hormone from the pituitary gland.

Without that LH surge, the ovaries simply do not release an egg.

If there is no egg, there could be no conception.

Makes sense, and the second mechanism acts as a backup at the cervix, right?

Precisely.

Under normal circumstances, estrogen makes cervical mucus thin and stretchy.

Kind of like egg whites, which creates a perfect swimming environment for sperm.

Okay.

E2 gestural counteracts that.

It significantly increases the viscosity of the cervical mucus.

It turns it into a thick, sticky, essentially impenetrable physical barrier.

Sperm simply cannot swim through it to reach the uterus.

Wow, that brings us to the third layer of defense, which involves the uterus itself.

Yeah, the continuous progestin exposure alters the endometrium,

the lining of the uterus.

Normally, that lining thickens every month to prepare for a fertilized egg.

Right, the normal cycle.

But the implant keeps that lining incredibly thin and atrophic.

It becomes a hostile, inhospitable environment where implantation simply cannot occur.

And the fourth point, which is super vital for patient counseling, is about what the implant does not do.

Yes, it is unequivocally not an abortifacient.

All three of the mechanisms we just discussed, stopping the egg, blocking the sperm, and thinning the lining, they all work proactively to prevent a fertilized egg from ever forming or implanting.

So it happens before pregnancy.

Exactly.

If a patient is already pregnant, inserting the implant will not disrupt or end that existing pregnancy.

Okay, so we have a tiny radiopic device providing a three -year, multi -layered biological shield.

With all that in mind, who is sitting across from us in the clinic?

Like, how does our history taking point us toward Nexplanon as the ideal choice?

Well, you are listening closely for specific clinical red flags during the history.

Nexplanon is a fantastic option for patients who absolutely cannot take estrogen.

Okay, like who?

If your patient has a history of severe migraines with aura, high blood pressure, or strong risk for blood clots, estrogen -containing methods like the combined pill or the ring are entirely off the table.

A progestin -only method becomes highly advantageous.

It also seems perfect for the patient who is honest about their lifestyle.

If someone says, I can never remember to take a pill at the same time every day, this just removes the user error entirely.

Oh, 100%.

Another major patient profile is the postpartum mother.

Progestin -only methods are highly compatible with breastfeeding.

That's good to know.

Yeah, the transfer of eutonic gestural into breast milk is minuscule less than 0 .2 % of the maternal dose.

More importantly,

unlike estrogen, it does not suppress milk production or alter the nutritional quality of the milk.

There are also systemic benefits, right?

Because the implant thins the uterine lining, patients generally experience less total blood loss over time compared to their natural cycles.

That's right.

That makes it a great option for a patient with a history of anemia because it helps stabilize their hemoglobin levels.

And we cannot ignore the socioeconomic factors.

The financial structure of the implant is very unique.

The device itself costs between $600 and $1 ,300.

And the insertion procedure adds another $125 to $300.

But that cost is paid entirely upfront and it's often covered by insurers or Medicaid.

Right.

So if a patient loses their health insurance six months later, their highly effective contraception remains fully active and paid for.

But the upfront costs can obviously be a barrier for uninsured patients.

And as we counsel them, we have to talk about the physical downsides too.

I mean, they're losing their autonomy, right?

They can't just stop taking it if they change their mind.

They have to come back to the clinic and have you numb their arm and literally cut it out.

Exactly.

That is a factor.

Plus it offers zero protection against sexually transmitted infections.

And then there's the big conversation about weight.

Right.

Weight changes are a significant source of anxiety for many patients considering hormones.

Let me stop you right there because patients always hear from a friend or a TikTok video that the implant guarantees massive weight gain.

Wait, if weight changes are a known disadvantage, does it exclusively cause weight gain?

I am so glad you brought that up because it is one of the most common myths you will encounter in practice.

The clinical data shows that weight fluctuations occur.

Women actually lose weight on the implant at the exact same statistical rate that other women gain it.

Really?

That's not what you hear online.

I know, but it's true.

Yeah.

And for those who do experience weight gain, the average is minimal, typically just two to three pounds over an entire year.

It is not the sudden severe weight gain that patients fear, but it is a physiological possibility so it must be part of your informed consent discussion.

That nuance changes the entire tone of the counseling.

But let's move to the real giant in the room, the absolute biggest clinical hurdle you will face with Nexpanon.

Irregular bleeding.

This is the single most common reason patients sit back down in your office totally frustrated, asking you to remove the implant early.

Yeah.

If you do not prepare your patient for this reality during the initial counseling, the method is almost guaranteed to fail for them.

The bleeding profile is completely chaotic.

They might have a few days of heavy bleeding, followed by weeks of spotting, or they might have amenorrhea, so no bleeding at all for six months, and then suddenly bleed for two weeks straight.

Exactly.

And here is a major trap clinicians fall into in the real world, assuming past behavior predicts future behavior.

It is a very dangerous assumption.

Yeah.

You might have a patient who used the Depo -Provera progestin shot for years and never bled once.

Do not promise them they will have the same experience with Nexpanon.

Because it's different.

The hormone delivery system is completely different.

The Depo shot creates massive peaks and troughs of hormone in the bloodstream, whereas the implant provides a low, steady state.

That subtle difference means their uterine lining will react entirely differently.

So a month goes by and the patient comes back.

They are tired of the unpredictable spotting and they just want the implant out.

Before we jump straight to removal, how do we medically manage this bleeding to treat and save the method?

Assuming the patient is otherwise medically stable and the bleeding isn't a sign of a new underlying pathology, we have three pharmacological management pathways.

The first and preferred line of defense is a course of NSAINs, specifically naproxen.

Wait, how does an over -the -counter painkiller stop uterine bleeding?

Good question.

NSAINs inhibit the synthesis of prostaglandins.

In the uterus, lowering prostaglandins changes the blood flow in the endometrial vessels, which can significantly reduce the volume of bleeding and spotting.

Oh, that makes sense.

Yeah, so you instruct the patient to take 440 milligrams of naproxen immediately and then repeat it every six to eight hours for five to seven days.

Because that is a heavy dose that can irritate the gastric lining, always counsel them to take it with a full meal.

Okay, what if the naproxen doesn't work and they are still spotting?

Option two involves using exogenous estrogen.

The spotting happens because the progestin from the implant has made the uterine lining so thin that the blood vessels become fragile and break down easily, creating microscopic ulcerations.

If you prescribe one standard cycle of combined oral contraceptives for one month,

that temporary boost of daily estrogen physically heals and stabilizes that fragile lining.

And if they can't take combined pills, option three is an off -label use of oral estradiol, about 20 to 25 micrograms daily for a month.

Using the exact same logic, just stabilize the fragile tissue.

Exactly, it's really just about getting them through that transition period.

Here's where it gets really interesting.

Despite all this frustration over unpredictable spotting, the data actually shows that over a 90 -day period, patients using Nexplanon experience fewer total bleeding days and less total blood volume than women not using any hormones at all.

It's a crazy statistic.

It is, it is not that they are bleeding more, it is just that the schedule of the bleeding has completely lost its mind.

That is incredibly helpful framing to use in the clinic.

When you explain that the overall volume is actually lower, it often helps patients tolerate the unpredictability while their body adjusts.

So we've counseled them on the weight, we've warned them about the bleeding, and they are fully on board.

Now we transition to safety.

Before we open the Scarrol packaging, what are the absolute red flags where this device simply cannot be used?

The absolute contraindications are strict.

First,

known or suspected pregnancy.

You never introduce exogenous hormones to an unknown pregnancy.

Obviously.

Second, any history of breast cancer.

Breast cancers are often hormone receptor positive, meaning they use hormones to grow.

You cannot introduce a continuous progestin source.

What about liver conditions?

Active liver disease or hepatic tumors are a hard stop.

The liver is the primary site of hormone metabolism.

If the liver is compromised, the patient cannot safely process the continuous ectonogestrel.

Right.

You also absolutely avoid this in patients with a history of thrombolytic disease, so active blood clots.

And finally, any undiagnosed abnormal genital bleeding.

If a patient is bleeding heavily and you don't know it's from a fibroid, an infection or malignancy,

you cannot mask the symptom by altering the uterine lining with an implant until you have a definitive diagnosis.

Beyond those hard stops, there are precautions conditions where you have to use serious clinical judgment.

Things like severe cardiovascular disease, systemic lupus erythematosus, severe cirrhosis, and diabetes.

But I want to zero in on a very specific safety checkpoint,

the patient's current medication list.

This is where understanding pharmacology is critical.

We have to look out for hepatic enzyme inducers.

So hepatic enzyme inducers are basically like putting the liver on a treadmill.

It speeds up the metabolism so much that it burns through the implant's hormones before they can actually do their job of stopping pregnancy.

That is a perfect visualization.

The liver uses a specific system of enzymes, the cytochrome P450 system, to break down chemicals.

If a patient is taking certain anti -seizure medications like phenytoin, carbamazepine, or topiramate, or certain antimicrobials like rifampin or grizafulvin, those drugs command the liver to produce more enzymes and work in overdrive.

So the liver starts chewing up the autonogestrel much faster than the implant is releasing it.

Precisely.

If we connect this to the bigger picture,

the steady state of hormone in the bloodstream plummets below the therapeutic threshold.

Wow.

The ovaries wake up, the cervical mucus thins out, and suddenly your patient is at high risk for an unintended pregnancy, all because of an interacting prescription.

That makes total sense.

To help navigate all these conditions and interactions, clinicians rely on the CDC US Medical Eligibility Criteria or the MEC.

It uses a one to four scale.

Category one means there is no restriction, use it freely.

Category two means the advantages generally outweigh the risks.

Category three means the risks usually outweigh the advantages.

And category four is an unacceptable health risk.

So a hard stop.

The MEC is your clinical roadmap.

For example, regarding postpartum use, the implant is a category one or two, depending on exactly how many days postpartum the patient is and their breastfeeding status.

What about after an abortion?

Conversely, if a patient is postabortion, whether it was first trimester, second trimester, or even a postseptic abortion, next one is immediately a category one.

You can safely place the implant before they even leave the facility.

All right, the history is solid.

The safety checks are clear and the patient is ready.

It is time for the physical clinical skill.

Step one,

timing the insertion.

We can't just put this in on any random Tuesday, right?

No, timing is everything to ensure we aren't inserting the device after ovulation has occurred or into a very early undetectable pregnancy.

The rules are strict.

If the patient has not been using any hormonal contraception, you insert the implant between days one and seven of their menstrual bleeding.

What if they are transitioning from the combined daily pill?

You insert it within seven days of them taking their last active pill.

If they're switching from a progestin -only pill, the mini pill, you can insert it at any time, provided they haven't missed a single pill that month.

And if they have an IUD that they want removed?

You can place the implant on the exact same day you pull the IUD.

But if your patient falls outside of all these specific windows, maybe they haven't had a period in months and aren't on hormones, you can still insert it.

Oh, really?

Yes.

However, you must establish that they aren't currently pregnant and you must firmly instruct them to use a non -hormonal backup method, like condoms, for seven full days while the implant builds up to a therapeutic level.

OK, the timing is correct.

The patient is lying down, their arm is flexed and supported by a pillow.

We use the non -dominant arm.

The clinical guidelines are incredibly granular about exactly where this goes.

Very granular.

We are instructed to measure eight to ten centimeters up from the medial condyle of the humerus, which is basically the bony bump on the inside of the elbow, and then measure three to five centimeters posterior to the sulcus, the groove between the biceps and triceps muscles.

Hold on.

Why be so incredibly precise with a tape measure?

Why not just put it anywhere on the back of the arm?

You absolutely cannot just eyeball this.

That specific three to five centimeter measurement isn't arbitrary.

It is the difference between a routine insertion and permanent nerve damage.

Oh, wow.

Yeah.

The sulcus, that groove between your biceps and triceps, is a major anatomical highway.

It houses the ulnar nerve and the large basilic vein.

So if you just guess and you place it too close to that groove, that's bad news.

You risk driving the applicator directly into a major blood vessel or striking the ulnar nerve, causing intense pain and potential loss of function.

You use the tape measure to ensure you are placing the implant three to five centimeters posterior to that groove, resting safely over the bulk of the triceps muscle where there are no major neurovascular structures.

Safety is achieved through strict anatomical respect.

The insertion itself is remarkably fast for an experienced clinician, usually taking just a minute or two under local anesthesia, but the single most critical moment of the entire visit happens the second you pull the empty applicator away.

The post -insertion palpation.

You do not let that patient leave the room until you physically feel both ends of that four -centimeter rod beneath the skin.

And more importantly, you must have the patient reach over and feel it themselves.

Why both ends?

Because if you can only feel one end or you can't feel it at all, you have to assume the device was placed too deeply intramuscularly rather than subdermally.

Deep placements are an absolute nightmare to remove later and can lead to migration.

By having the patient feel it, they know exactly what normal feels like.

So if it ever shifts, they can alert you.

You then apply a pressure bandage to stop the bleeding and minimize bruising, fill out the patient's user tracking card, and complete your clinical documentation.

And fast forward three years, when it's time for removal, the process is pretty straightforward.

Removal usually takes about five to ten minutes with minimal discomfort.

You numb the area, make a tiny incision at the tip, and gently push the rod out.

The guidelines specify you remove it at the end of the three years if the patient wants to conceive, if they want to switch methods, or if they are experiencing intolerable side effects.

Right.

And the beauty of the system is that if they want continued protection, you can insert a brand new Nexplanon through the exact same incision right then and there.

So what does this all mean?

It means that mastering this clinical procedure is about so much more than knowing how to hold a creatively managing the bleeding side effects, respecting the liver's pharmacology, and demanding anatomical perfection during insertion, you are equipping yourself to offer safe, highly effective care to the people who trust you with their reproductive health.

Yeah.

And you know, it is worth mulling over just how profoundly these devices change the clinical relationship.

Long -acting reversible contraceptives offer patients incredible physiological freedom.

They require zero daily maintenance.

It's true.

But to gain that freedom, the patient inherently shifts the physical control of starting and stopping their contraception away from their own bathroom sink and places it squarely in your hands at the clinician's office.

It is a fascinating dynamic in the landscape of reproductive autonomy.

It highlights just how vital a deeply trusting, well -informed relationship between you and your patient truly is.

That is a beautiful way to frame the responsibility of this skill.

To all the nursing and advanced practice students listening, a warm thank you from the last minute lecture team.

We hope this deep dive brought the clinical guidelines to life.

We wish you the absolute best of luck in your clinicals and your exams.

You've got this.

Take care.